Oral Cancer Treatment Market Was Estimated At USD 1,750 Million In 2021, And It Is Anticipated To Reach About USD 2,700 Million In 2030

The market for oral cancer treatment was estimated at USD 1,750 million in 2021, and it is anticipated to reach about USD 2,700 million in 2030 registering a CAGR of 4.5% during the coming years.

The growth of the global oral cancer treatment market is significantly due to rise in prevalence of oral or mouth cancer globally fostering the growth of the market. As per the data of Oral Cancer Foundation, annually around 53,000 new oral cancer cases are identified and above 9,750 people succumb to the disease in the U.S. Similarly, oral cancer registers for 4% of total cancer cases and causes 2.2% deaths in the U.S. In western nations, prevalence of oral cancer is 2% to 6% of the overall cancer incidences.

The growing healthcare expenditure, rising consumption of tobacco products such as cigarettes, cigars, pipes and chewing tobacco and rise in the special designation from regulatory experts are other factors also boosting the growth of the market. Upsurge in personal disposable income together with rise in prevalence of papillomavirus infection is other indirect element that will create productive market growth opportunities. However, dearth of awareness about the oral cancer in the backward and underdeveloped areas will hinder the market growth. Risk of reappearance even after the treatment will also obstruct the market growth rate.

Download a Sample Copy of Oral Cancer Treatment Market: https://analyticsmarketresearch.com/sample-request/oral-cancer-treatment-market/663/

The outbreak of COVID-19 hampered the global market for oral cancer treatment. All the healthcare settings were engaged in the treatment of the COVID patients globally. Therefore, only the emergency cases and critical treatments were performed during the pandemic. Due to the lockdowns in various nations, the demand for oral cancer treatment has considerably decreased due to the limitation of people in moving freely and also people reducing their appointments to the health care places until an emergency. Owing to the COVID 19 effect, it has been witnessed that a large number of oral cancer treatment enterprises are enforced to lay off employees but it is presumed that the market will soon pick up the pace and the demand would grow. It is projected that the post-lockdown period would be a positive period for the oral cancer treatment market revenue. It is also analysed that every section would be contributing significantly towards the growth of oral cancer treatment market value.

Type Insights
The squamous cell carcinoma (SCC) segment is expected to dominate the market over the forecast amount. Squamous cell carcinoma (SCC) is the mostly affected type of oral cancer, accounting for around 90% of all cases. It generally forms on the tongue, lips, or inside the cheeks. Untreated, squamous cell carcinoma of the skin can nurture large or spread to other parts of the body, causing severe obstacles.

Therapy Type Insights
The chemotherapy market is anticipated to grow at a significant rate during the forecast period due to increasing cases of oral cancer treatment globally. Chemotherapy is used at different times in the treatment process for oral cavity or oropharyngeal cancers. Chemotherapy is with anti-cancer drugs that are inserted into a vein or taken by mouth that enters the blood and reach most parts of the body.

Region Insights
North America dominates the oral cancer treatment market due to the increasing affordability of drugs and upsurge in the cases of oral cancer. The region is also experiencing vast growth in oral cancer market shares as the countries in this region have been gaining the benefits of technology thus maximizing the level of operations and reducing operational cost.
However, Asia-Pacific is anticipated to have the highest growth rate and exhibit the highest CAGR for the forecast period. This is due to the rising expenditure to develop healthcare infrastructure and growing consumption of tobacco. The large proportion of the young populace living in these nations and the rising demand for tobacco and alcohol in these countries which are the major reasons of oral cancer.

Key Companies Insights
Key players are aiming on their technological partnerships, collaborations, and merger & acquisitions strategies to increase a competitive edge and expand their product portfolio & business footmark. The ongoing Covid-19 pandemic hampered the systems worldwide and drove market players to innovate products for unexploited opportunities.

Some of the key players operating in the global oral cancer treatment market include:
• F. Hoffmann-La Roche Ltd
• Novartis AG
• Pfizer Inc.
• Merck & Co., Inc.
• GlaxoSmithKline plc
• Cipla Inc.
• Teva Pharmaceutical Industries Ltd
• Fresenius Kabi AG
• Bristol-Myers Squibb Company
• Sanofi
• Mylan N.V.
• Celgene Corporation
• Intas Pharmaceuticals Ltd
• Amneal Pharmaceuticals LLC
• Zydus Cadila
• Takeda Pharmaceutical Company Limited
• Lupin Pharmaceuticals, Inc.
• Eli Lilly and Company
• Sun Pharmaceutical Industries Ltd.
• AstraZeneca
• Pfizer Inc.
• Other players

Some of the Recent Developments:
• Nanotechnology-based carrier systems have been introduced for oral cancer treatment whereby due to chemical and physical properties the nanoparticles show an increased response towards the drug delivery system and also reduce toxicity associated with the treatment process.

• In 2021, Takeda Pharmaceutical company announced that it is going to acquire Gammadelta therapeutics Limited, a company that has been engrossed on using unique properties of cells for immunotherapy. This allowed the company to use all the intellectual rights of the acquired company to its benefit.

• In 2021, Roche launched the latest profiling kit that helps cancer researchers to investigate tumors easily without having to send tissue samples to centralized laboratories. This would be a significant boost in the medical cancer research market.

Direct Purchase Oral Cancer Treatment Market Research Report: https://analyticsmarketresearch.com/purchase/oral-cancer-treatment-market/663/?license=single

Segments
By Type
• Squamous Cell Carcinoma
• Verrucous Carcinoma
• Minor Salivary Gland Carcinomas
• Lymphomas

By Therapy Type
• Chemotherapy
• Immunotherapy
• Targeted Therapy

By Age Group
• 30-49
• 50-69
• 70 and above

By Geography
• North America
o U.S.
o Canada
o Mexico
• Europe
o U.K.
o Germany
o France
o Italy
o Spain
o Russia
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o ASEAN
• Latin America
o Brazil
o Argentina
o Colombia
• MEA
o South Africa
o Saudi Arabia
o UAE
o Egypt

Frequently Asked Questions
• What is the market size and growth projections?
• What is the market size and growth projection for each of the market segments and sub-segments across Countries & Regions?
• What are the top performing segments, and countries / regions of each of the markets?
• What is the market size and growth rate across key countries / regions?
• How big is the global & regional market in terms of revenue and volume?
• How far market will grow in forecast period in terms of revenue and volume?
• What factors will influence demand and supply trends across each markets during the forecast period?
• What are the technology trends shaping various markets?
• Which country / region has more opportunities?
• What is the COVID-19 impact on the market and how long will it take to recover?
• Who are the key competitors of market Players?
• What are the market share (%) of Key Players?
• What are the Merger & Acquisition, New Product Launch, Recent Development within each of the Markets?
• What are PEST analysis, Ecosystem Analysis, Porter's Five Forecast Analysis, Ansoff Matrix, and SWOT Analysis among other analyses for diverse markets?

Read More: https://analyticsmarketresearch.com/reports/oral-cancer-treatment-market/663/

Contact US:
Analytics Market Research
99 WALL STREET, #2124 NEW YORK, NY 10005
Phone: +1(650)-666-4592
Email: sales@analyticsmarketresearch.com
Web: https://analyticsmarketresearch.com/

About US:
Analytics Market Research is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep rooted market studies and insightful analysis of different markets.

Our strategic market analysis and capability to comprehend deep cultural, conceptual and social aspects of various tangled markets has helped us make a mark for ourselves in the industry. Analytics Market Research is a frontrunner in helping numerous companies; both regional and international to successfully achieve their business goals based on our in-depth market analysis. Moreover, we are also capable of devising market strategies that ensure guaranteed customer bases for our clients.

This release was published on openPR.